{"id":27206,"date":"2019-04-28T13:38:43","date_gmt":"2019-04-28T11:38:43","guid":{"rendered":"https:\/\/kymos.com\/news\/qualita-ed-equivalenza-dei-prodotti-topici\/"},"modified":"2019-04-28T13:38:43","modified_gmt":"2019-04-28T11:38:43","slug":"qualita-ed-equivalenza-dei-prodotti-topici","status":"publish","type":"post","link":"https:\/\/kymos.com\/it\/news\/qualita-ed-equivalenza-dei-prodotti-topici\/","title":{"rendered":"Qualit\u00e0 ed equivalenza dei prodotti topici"},"content":{"rendered":"<p><span style=\"font-size: 14pt;\">Il 18 ottobre 2018 l&#8217;EMA ha pubblicato la <a href=\"https:\/\/www.ema.europa.eu\/documents\/scientific-guideline\/draft-guideline-quality-equivalence-topical-products_en.pdf\" data-wpel-link=\"external\">bozza delle linee guida sulla qualit\u00e0 e l&#8217;equivalenza dei prodotti topici<\/a> . Il 30 giugno 2019 si concluder\u00e0 il periodo di consultazione e si prevede che entreranno in vigore entro la fine dell&#8217;anno. Le linee guida stabiliscono chiaramente che le domande di autorizzazione all&#8217;immissione in commercio basate sulla letteratura per dimostrare la sicurezza e l&#8217;efficacia devono essere supportate da dati di equivalenza della formulazione. Allo stesso tempo, forniscono dettagli sui modelli <i>in vivo<\/i> e <i>in vitro<\/i> che possono sostituire i dati clinici e quando sono applicabili i biowaiver. Le linee guida riguardano specificamente: <b>test di rilascio <i>in vitro<\/i><\/b> ( <b>IVRT<\/b> ), <b>studi di permeazione cutanea <i>in vitro<\/i><\/b> ( <b>IVPT<\/b> ), campionamento dello strato corneo mediante stripping con nastro adesivo e test di vasocostrizione per i corticosteroidi.    <\/span><\/p>\n<div class=\"blog-content\">\n<div class=\"field field-name-body field-type-text-with-summary field-label-hidden\">\n<div class=\"field-items\">\n<div class=\"field-item even\">\n<p><span style=\"font-size: 14pt;\"><b>L&#8217;IVRT<\/b> non \u00e8 un modello di prestazione <i>in vivo<\/i> della formulazione, ma pu\u00f2 essere utilizzato come attributo di qualit\u00e0 per il rilascio del lotto e le specifiche di shelf-life. L&#8217;IVRT \u00e8 finalizzato a valutare la velocit\u00e0 e l&#8217;estensione del rilascio di un principio attivo nella formulazione attraverso una membrana e i parametri da testare sono la velocit\u00e0 di rilascio del farmaco, la quantit\u00e0 cumulativa e il tempo di latenza. <\/span><\/p>\n<p><span style=\"font-size: 14pt;\"><b>L&#8217;IVPT<\/b> utilizza la pelle umana in studi discriminativi per dimostrare l&#8217;equivalenza tra una formulazione sperimentale e un comparatore noto, evitando cos\u00ec studi clinici con endpoint di efficacia. Gli studi pilota e pivotal devono essere condotti in linea con l&#8217;ICH E8 in termini di randomizzazione e cecit\u00e0. <\/span><\/p>\n<p><span style=\"font-size: 14pt;\"><b>L&#8217;IVPT<\/b> pu\u00f2 essere utilizzato anche per valutare la mancanza di assorbimento di sostanze farmacologiche, cosmetici o biocidi con attivit\u00e0 locale che non dovrebbero essere assorbiti per motivi di sicurezza.<\/span><\/p>\n<p><span style=\"font-size: 14pt;\"><b>IVRT<\/b> e <b>IVPT<\/b> vengono solitamente eseguite utilizzando celle a diffusione verticale, tra cui le cosiddette celle di Franz, le pi\u00f9 comunemente utilizzate. L&#8217;uso di strumenti automatizzati riduce la variabilit\u00e0, soprattutto quando si utilizza la pelle di donatori, e con il software appropriato, fornisce risultati affidabili conformi alla norma 21 CFR parte 11. <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">Dal punto di vista della qualit\u00e0, l&#8217;utilizzo di test in vitro per i prodotti topici \u00e8 uno strumento importante per sviluppare formulazioni coerenti durante il loro ciclo di vita e diventer\u00e0 un attributo per certificare la qualit\u00e0 e l&#8217;omogeneit\u00e0 dei lotti di produzione. Dal punto di vista dell&#8217;equivalenza, rappresenta una porta aperta alla registrazione di prodotti generici a costi accessibili e avr\u00e0 un impatto significativo negli anni a venire sull&#8217;accesso al mercato di questi prodotti. <\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Il 18 ottobre 2018 l&#8217;EMA ha pubblicato la bozza delle  [&#8230;]<\/p>\n","protected":false},"author":6,"featured_media":27208,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[253,264],"tags":[],"class_list":["post-27206","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bioanalisi","category-cmc"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Qualit\u00e0 ed equivalenza dei prodotti topici | Kymos<\/title>\n<meta name=\"description\" content=\"Scopri di pi\u00f9 sulle linee guida sulla qualit\u00e0 e l&#039;equivalenza dei prodotti topici e sui dettagli dei modelli in vivo e in vitro.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kymos.com\/it\/news\/qualita-ed-equivalenza-dei-prodotti-topici\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Qualit\u00e0 ed equivalenza dei prodotti topici | Kymos\" \/>\n<meta property=\"og:description\" content=\"Scopri di pi\u00f9 sulle linee guida sulla qualit\u00e0 e l&#039;equivalenza dei prodotti topici e sui dettagli dei modelli in vivo e in vitro.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kymos.com\/it\/news\/qualita-ed-equivalenza-dei-prodotti-topici\/\" \/>\n<meta property=\"og:site_name\" content=\"Kymos\" \/>\n<meta property=\"article:published_time\" content=\"2019-04-28T11:38:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kymos.com\/wp-content\/uploads\/2019\/04\/hanson_franz_cells_copy_Topical-Products.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"825\" \/>\n\t<meta property=\"og:image:height\" content=\"350\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Joan Puig de Dou\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@KymosGroup\" \/>\n<meta name=\"twitter:site\" content=\"@KymosGroup\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"Joan Puig de Dou\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/qualita-ed-equivalenza-dei-prodotti-topici\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/qualita-ed-equivalenza-dei-prodotti-topici\\\/\"},\"author\":{\"name\":\"Joan Puig de Dou\",\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/#\\\/schema\\\/person\\\/264c93ce9dcf43caa9d634aeafab965c\"},\"headline\":\"Qualit\u00e0 ed equivalenza dei prodotti topici\",\"datePublished\":\"2019-04-28T11:38:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/qualita-ed-equivalenza-dei-prodotti-topici\\\/\"},\"wordCount\":414,\"image\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/qualita-ed-equivalenza-dei-prodotti-topici\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/hanson_franz_cells_copy_Topical-Products.jpg\",\"articleSection\":[\"Bioanalisi\",\"CMC\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/qualita-ed-equivalenza-dei-prodotti-topici\\\/\",\"url\":\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/qualita-ed-equivalenza-dei-prodotti-topici\\\/\",\"name\":\"Qualit\u00e0 ed equivalenza dei prodotti topici | Kymos\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/qualita-ed-equivalenza-dei-prodotti-topici\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/qualita-ed-equivalenza-dei-prodotti-topici\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/hanson_franz_cells_copy_Topical-Products.jpg\",\"datePublished\":\"2019-04-28T11:38:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/#\\\/schema\\\/person\\\/264c93ce9dcf43caa9d634aeafab965c\"},\"description\":\"Scopri di pi\u00f9 sulle linee guida sulla qualit\u00e0 e l'equivalenza dei prodotti topici e sui dettagli dei modelli in vivo e in vitro.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/qualita-ed-equivalenza-dei-prodotti-topici\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/qualita-ed-equivalenza-dei-prodotti-topici\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/qualita-ed-equivalenza-dei-prodotti-topici\\\/#primaryimage\",\"url\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/hanson_franz_cells_copy_Topical-Products.jpg\",\"contentUrl\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/hanson_franz_cells_copy_Topical-Products.jpg\",\"width\":825,\"height\":350,\"caption\":\"hanson_franz_cell\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/qualita-ed-equivalenza-dei-prodotti-topici\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/kymos.com\\\/it\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Qualit\u00e0 ed equivalenza dei prodotti topici\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/#website\",\"url\":\"https:\\\/\\\/kymos.com\\\/it\\\/\",\"name\":\"Kymos Group\",\"description\":\"Kymos Group\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/kymos.com\\\/it\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/kymos.com\\\/it\\\/#\\\/schema\\\/person\\\/264c93ce9dcf43caa9d634aeafab965c\",\"name\":\"Joan Puig de Dou\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g\",\"caption\":\"Joan Puig de Dou\"},\"description\":\"Active in the pharmaceutical marketing for over 30 years President of CataloniaBIO&amp;HealthTech CEO and Qualified Person at Kymos Leader of Kymos team, guaranteeing a trustable, ethical and scientific correct editorial publications. Experience Joan Puig de Dou started his career at Laboratorios Menarini first as scientist later as Qualified Person and finally as Operations General Manager. 2010 he entered Kymos where he became CEO in 2015. 2022 Joan Puig de Dou was elected as president of CataloniaBio&amp;HealthTech to represent the Catalonian biotech industry nationally and internationally. Expertise Joan Puig de Dou has extensive experience in writing scientific content adopting a didactic approach that fits any reader\u2019s level of expertise. He publishes regularely on Kymos\u2019 webpage, social media and in the specialized press. Education He graduated from Universitat de Barcelona as Pharmacist and from IESE Business School\u2019s Programa Diecci\u00f3n General (PDG) Want to know him better? Read his interview in PharmaBoardrooom in January 2019 and more about his presidency of CataloniaBio at Parc Sc\u00edentific de Barcelona.\",\"url\":\"https:\\\/\\\/kymos.com\\\/it\\\/news\\\/author\\\/joan-puig-de-dou\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Qualit\u00e0 ed equivalenza dei prodotti topici | Kymos","description":"Scopri di pi\u00f9 sulle linee guida sulla qualit\u00e0 e l'equivalenza dei prodotti topici e sui dettagli dei modelli in vivo e in vitro.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kymos.com\/it\/news\/qualita-ed-equivalenza-dei-prodotti-topici\/","og_locale":"it_IT","og_type":"article","og_title":"Qualit\u00e0 ed equivalenza dei prodotti topici | Kymos","og_description":"Scopri di pi\u00f9 sulle linee guida sulla qualit\u00e0 e l'equivalenza dei prodotti topici e sui dettagli dei modelli in vivo e in vitro.","og_url":"https:\/\/kymos.com\/it\/news\/qualita-ed-equivalenza-dei-prodotti-topici\/","og_site_name":"Kymos","article_published_time":"2019-04-28T11:38:43+00:00","og_image":[{"width":825,"height":350,"url":"https:\/\/kymos.com\/wp-content\/uploads\/2019\/04\/hanson_franz_cells_copy_Topical-Products.jpg","type":"image\/jpeg"}],"author":"Joan Puig de Dou","twitter_card":"summary_large_image","twitter_creator":"@KymosGroup","twitter_site":"@KymosGroup","twitter_misc":{"Scritto da":"Joan Puig de Dou","Tempo di lettura stimato":"2 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/kymos.com\/it\/news\/qualita-ed-equivalenza-dei-prodotti-topici\/#article","isPartOf":{"@id":"https:\/\/kymos.com\/it\/news\/qualita-ed-equivalenza-dei-prodotti-topici\/"},"author":{"name":"Joan Puig de Dou","@id":"https:\/\/kymos.com\/it\/#\/schema\/person\/264c93ce9dcf43caa9d634aeafab965c"},"headline":"Qualit\u00e0 ed equivalenza dei prodotti topici","datePublished":"2019-04-28T11:38:43+00:00","mainEntityOfPage":{"@id":"https:\/\/kymos.com\/it\/news\/qualita-ed-equivalenza-dei-prodotti-topici\/"},"wordCount":414,"image":{"@id":"https:\/\/kymos.com\/it\/news\/qualita-ed-equivalenza-dei-prodotti-topici\/#primaryimage"},"thumbnailUrl":"https:\/\/kymos.com\/wp-content\/uploads\/2019\/04\/hanson_franz_cells_copy_Topical-Products.jpg","articleSection":["Bioanalisi","CMC"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/kymos.com\/it\/news\/qualita-ed-equivalenza-dei-prodotti-topici\/","url":"https:\/\/kymos.com\/it\/news\/qualita-ed-equivalenza-dei-prodotti-topici\/","name":"Qualit\u00e0 ed equivalenza dei prodotti topici | Kymos","isPartOf":{"@id":"https:\/\/kymos.com\/it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kymos.com\/it\/news\/qualita-ed-equivalenza-dei-prodotti-topici\/#primaryimage"},"image":{"@id":"https:\/\/kymos.com\/it\/news\/qualita-ed-equivalenza-dei-prodotti-topici\/#primaryimage"},"thumbnailUrl":"https:\/\/kymos.com\/wp-content\/uploads\/2019\/04\/hanson_franz_cells_copy_Topical-Products.jpg","datePublished":"2019-04-28T11:38:43+00:00","author":{"@id":"https:\/\/kymos.com\/it\/#\/schema\/person\/264c93ce9dcf43caa9d634aeafab965c"},"description":"Scopri di pi\u00f9 sulle linee guida sulla qualit\u00e0 e l'equivalenza dei prodotti topici e sui dettagli dei modelli in vivo e in vitro.","breadcrumb":{"@id":"https:\/\/kymos.com\/it\/news\/qualita-ed-equivalenza-dei-prodotti-topici\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kymos.com\/it\/news\/qualita-ed-equivalenza-dei-prodotti-topici\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/kymos.com\/it\/news\/qualita-ed-equivalenza-dei-prodotti-topici\/#primaryimage","url":"https:\/\/kymos.com\/wp-content\/uploads\/2019\/04\/hanson_franz_cells_copy_Topical-Products.jpg","contentUrl":"https:\/\/kymos.com\/wp-content\/uploads\/2019\/04\/hanson_franz_cells_copy_Topical-Products.jpg","width":825,"height":350,"caption":"hanson_franz_cell"},{"@type":"BreadcrumbList","@id":"https:\/\/kymos.com\/it\/news\/qualita-ed-equivalenza-dei-prodotti-topici\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kymos.com\/it\/"},{"@type":"ListItem","position":2,"name":"Qualit\u00e0 ed equivalenza dei prodotti topici"}]},{"@type":"WebSite","@id":"https:\/\/kymos.com\/it\/#website","url":"https:\/\/kymos.com\/it\/","name":"Kymos Group","description":"Kymos Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kymos.com\/it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Person","@id":"https:\/\/kymos.com\/it\/#\/schema\/person\/264c93ce9dcf43caa9d634aeafab965c","name":"Joan Puig de Dou","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/secure.gravatar.com\/avatar\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g","caption":"Joan Puig de Dou"},"description":"Active in the pharmaceutical marketing for over 30 years President of CataloniaBIO&amp;HealthTech CEO and Qualified Person at Kymos Leader of Kymos team, guaranteeing a trustable, ethical and scientific correct editorial publications. Experience Joan Puig de Dou started his career at Laboratorios Menarini first as scientist later as Qualified Person and finally as Operations General Manager. 2010 he entered Kymos where he became CEO in 2015. 2022 Joan Puig de Dou was elected as president of CataloniaBio&amp;HealthTech to represent the Catalonian biotech industry nationally and internationally. Expertise Joan Puig de Dou has extensive experience in writing scientific content adopting a didactic approach that fits any reader\u2019s level of expertise. He publishes regularely on Kymos\u2019 webpage, social media and in the specialized press. Education He graduated from Universitat de Barcelona as Pharmacist and from IESE Business School\u2019s Programa Diecci\u00f3n General (PDG) Want to know him better? Read his interview in PharmaBoardrooom in January 2019 and more about his presidency of CataloniaBio at Parc Sc\u00edentific de Barcelona.","url":"https:\/\/kymos.com\/it\/news\/author\/joan-puig-de-dou\/"}]}},"_links":{"self":[{"href":"https:\/\/kymos.com\/it\/wp-json\/wp\/v2\/posts\/27206","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kymos.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kymos.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kymos.com\/it\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/kymos.com\/it\/wp-json\/wp\/v2\/comments?post=27206"}],"version-history":[{"count":0,"href":"https:\/\/kymos.com\/it\/wp-json\/wp\/v2\/posts\/27206\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kymos.com\/it\/wp-json\/wp\/v2\/media\/27208"}],"wp:attachment":[{"href":"https:\/\/kymos.com\/it\/wp-json\/wp\/v2\/media?parent=27206"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kymos.com\/it\/wp-json\/wp\/v2\/categories?post=27206"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kymos.com\/it\/wp-json\/wp\/v2\/tags?post=27206"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}